01.11.2012 • News
Novartis
25.09.2012 • Topics • Technology
Stick to Your Strengths with Biosimilars
20.08.2012 • News
Showdown for Big Pharma in India's Highest Court
27.07.2012 • News
U.S. Health Advisers Back Two New Eye Treatments
26.07.2012 • News
EU Crisis Piles on Pain for Europe's Drugmakers
24.07.2012 • News
Biogen Q2 Profit Up on MS Drug Sales
19.07.2012 • News
Novartis on Track despite Bigger Dollar Hit
19.06.2012 • News
US Top Court Rules for Glaxo on Overtime Pay
30.05.2012 • News
Stada to Seek Deals as Sector Consolidates
24.04.2012 • News
Watson, Actavis to Unveil Deal
02.04.2012 • News
Chasing Cheaper Cancer Drugs
12.03.2012 • News
Bayer Sounds Out Debt Market with Eye On Deals
03.11.2011 • News
Global Pharma to Pump Cash Into Russia
31.10.2011 • News
Lonza Sees Growth on Pharma Outsourcing
19.07.2011 • News
Novartis Posts Higher Q2 Profit
11.07.2011 • News
Bayer Loses European Patent For Yasmin
19.05.2011 • News
Bidders Emerge For Gen-Probe, Phadia
14.04.2011 • News
Roche Seen Kicking off Q1 Season With Sales Drop
12.04.2011 • News
Merck KGaA Eyes Job Cuts at Drugs Unit
11.04.2011 • News
Novartis Eyes Debts, Possible Smaller Buys
28.03.2011 • News
Andre Hoffmann: Roche Will Not Be For Sale
22.03.2011 • News
Bayer in U.S. Accused of Discrimination
Chemical Market Reporter
Frost & Sullivan
Microinnova Engineering GmbH
Oracle Germany
EvaluatePharma
Thomson Reuters
GlobalData
Merck KGaA
Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences
F. Hoffmann-La Roche Ltd
CONTINUUS Pharmaceuticals, Inc.
Camelot Management Consultants AG
KPMG
Arthur D. Little
SchüllerConsulting
Styron Europe GmbH
Novartis Vaccines and Diagnostics GmbH & Co.KG
Novartis International AG
ACIB Austrian Centre of Industrial Biotechnology
Getec Group
Isomorphic Labs
ISPE D/A/CH e.V.
Novartis Pharma GmbH